StonvexLoading…
StonvexStonvexStonvexCore line items from CLOQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 |
|---|---|---|---|---|
Revenue | $15.00K | $15.00K | $15.00K | $15.00K |
Operating Income | $-752.93K | $-502.42K | $-358.06K | $-196.03K |
Net Income | $-989.45K | $-680.69K | $-217.99K | $-246.81K |
EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $0.00 |
Total Assets | $1.84M | $1.67M | $1.50M | $1.41M |
Total Liabilities | $2.83M | $2.50M | $2.13M | $1.32M |
Cash & Equivalents | $282.87K | $190.16K | $141.51K | $127.15K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 128.79M | 125.84M | 125.54M | 125.44M |